Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)

NCT01499888 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT01499888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 11, 2011
Completion date
October 31, 2029
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease